Septerna, Inc. (SEPN)
Septerna, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Septerna, Inc. (SEPN) is a Biotechnology company based in US with a market capitalization of $1.4B. Revenue grew 4174.5% year-over-year and the company generated $109.7M in free cash flow. This page tracks SEPN's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 75 employees · IPO Oct 25, 2024
Valuation
Valuation & price
$26.95as of May 17, 2026· -27.8% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
3.57
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$1.4B
Market cap
4174.5%
Revenue growth (YoY)
100.0%
Gross margin
$109.7M
Free cash flow (USD)
-$367.5M
Net debt
Net cash position
19.0%
Share dilution
1/4
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2023 → 2025
Free cash flow by year
2022 → 2025
Gross margin by year
2023 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
7
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 11, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- Insider sellJul 2, 2026Filing
Insider Sell $115K · 10b5-1 PlanLong Daniel D. · SVP, Drug Discovery · $114.5K
- Insider sellJun 30, 2026Filing
Insider Sell $77K · 10b5-1 PlanShaikhly Samira · Chief People Officer · $76.6K
- 8-K eventJun 30, 2026Filing
Director Election and Auditor Ratification
- Insider sellJun 24, 2026Filing
Insider Sell $533K · 10b5-1 PlanLong Daniel D. · SVP, Drug Discovery · $532.6K
- Insider sellJun 16, 2026Filing
Insider Sell $219K · 10b5-1 PlanShaikhly Samira · Chief People Officer · $219.2K
- Insider sellJun 3, 2026Filing
Insider Sell $172K · 10b5-1 PlanShaikhly Samira · Chief People Officer · $171.7K
- Insider sellMay 28, 2026Filing
Insider Sell $355K · 10b5-1 PlanShaikhly Samira · Chief People Officer · $354.7K
- 8-K eventMay 11, 2026Filing
Earnings Release
- Quarterly reportMay 11, 2026Filing
10-Q Filed
- Insider sellApr 17, 2026Filing
Insider Sell $97K · 10b5-1 PlanBhatt Elizabeth · President and COO · $97.3K
Questions
Frequently asked questions
What is Septerna, Inc.'s market cap?
Septerna, Inc. (SEPN) has a market capitalization of $1.4B.
What is SEPN's P/E ratio?
A meaningful P/E ratio is not available for SEPN — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is SEPN's price-to-book (P/B) ratio?
SEPN trades at 3.57 times book value per share.
Are insiders buying SEPN stock?
SEC Form 4 filings show no open-market insider buys at Septerna, Inc. in the last 90 days (7 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.